SPARC and neuroblastoma: The results suggested a significant reduction of phosphorylated AKT in SPARC-inhibited neuroblastoma cell lines when PTEN was overexpressed, suggesting that PTEN plays an important role in inhibition of proliferation with the combination treatment (Fig. 6A).